论文信息 - Minimal Residual Disease (MRD) Assessment before and after Autologous Hematopoietic Cell Transplantation (AutoHCT) and Maintenance for Multiple Myeloma (MM): Results of the Prognostic Immunophenotyping for Myeloma Response (PRIMeR) Study - 字舞流文

Minimal Residual Disease (MRD) Assessment before and after Autologous Hematopoietic Cell Transplantation (AutoHCT) and Maintenance for Multiple Myeloma (MM): Results of the Prognostic Immunophenotyping for Myeloma Response (PRIMeR) Study

N. Geller | A. Krishnan | P. Hari | P. Wallace | M. Pasquini | Y. Efebera | P. McCarthy | D. Vesole | G. Somlo | J. Tario | T. Hahn | S. Giralt | H. Landau | E. Stadtmauer | D. Vogl | N. Shah | C. Brunstein | M. Fei | J. Koreth | A. Howard | B. Blackwell | R. Fraser | Yali Zhang | Kristin Knust